Growth vs. Value: Which Investing Style Wins for Europeans in 2026?

Let’s cut through the noise: In 2026, blindly sticking with either growth or value stocks in Europe is a recipe for mediocrity—one style is about to trounce the other, and most investors are on the wrong side. For years, European investors have watched US growth stocks run laps around stodgy value names. But the tide is shifting. If you’re not paying attention to how the growth vs value stocks Europe 2026 battle is setting up, you’re at risk of missing the next major rotation.

Here’s my thesis: European value stocks are poised to outshine growth by the end of 2026, but most portfolios—especially those “diversified” by American standards—are set up to miss this comeback. The data is lining up, the risks are clear, and the ETF options are finally less embarrassing. Here’s why you need to rethink your allocation—now.

Growth’s Decade-Long Domination: Why It’s Fading in Europe

Let’s acknowledge the scoreboard: Growth stocks, led by the US, have shredded value for more than a decade. In Europe, MSCI Europe Growth returned 11.6% annually (EUR terms) from 2013 to 2021, compared to just 6.9% for MSCI Europe Value. The numbers don’t lie.

Even in 2023, with rate hikes and war jitters, the iShares MSCI Europe SRI UCITS ETF (Dist) returned 18.2%, while the value-focused Lyxor MSCI Europe Value (DR) UCITS ETF managed just 10.7%. Tech, healthcare, and luxury—growth sectors—kept outperforming as investors clung to the “higher for longer” narrative on rates.

But here’s the catch: European growth is running out of steam. The Stoxx Europe 600 Technology Index trades at a nosebleed 27x forward earnings. Meanwhile, the European Central Bank is already cutting rates ahead of the Fed. The growth trade is no longer a one-way bet—especially in EUR terms.

Growth stocks in Europe are priced for perfection, but the macro backdrop is anything but perfect: expect disappointment.

The Value Revival: Why 2026 Will Be Europe’s Year

If you’re a European investor, you should be salivating over value right now. Dividends are back in fashion. The Eurozone inflation scare is fading. And in 2024, the MSCI Europe Value index has outpaced growth for the first time since 2019—posting a 7.4% gain versus 4.8% for growth as of May 2024.

Banking, energy, and industrials—the heart of European value—are set for a renaissance. Just look at BNP Paribas (BNP.PA): up 22% in 2024 YTD, with a 5.7% dividend yield. Or consider TotalEnergies (TTE.PA), which hiked its payout and trades at a mere 8x earnings. Europe’s value stocks are not the dinosaurs you think; they’re cash-generating machines with fortress balance sheets.

The ETF landscape is evolving, too. The iShares MSCI Europe Value Factor UCITS ETF (IEVL) now boasts €1.2 billion in AUM and a 3.9% dividend yield—finally, respectable scale. Investors who ignored value in 2023 missed out, and this gap is only widening in 2026 as monetary policy loosens.

In falling rate environments, value historically outperforms: from 2003-2006, European value stocks returned 17% annualised vs. 13% for growth (MSCI data).

Risk, Return, and the ETF Reality Check

Let’s talk risk. Growth ETFs like Invesco NASDAQ Next Generation UCITS ETF (EQQQ) draw in European money—but when you own EUR, you’re also exposed to USD swings and the whims of US tech. In 2022, EQQQ lost 30% in EUR terms, while the SPDR MSCI Europe Value UCITS ETF (IEVL) dropped just 8%. That’s not “diversification” if you’re haemorrhaging in a downturn.

Meanwhile, value’s volatility is plummeting. The 3-year standard deviation for MSCI Europe Value is just 12.6%, compared to 16.3% for growth. That means less stomach-churning—and more reliable income. If you’re after a smoother ride and real returns in euros, the maths is clear.

Of course, don’t expect a straight line up. Value can lag in rip-roaring bull runs, but in a world of falling rates, sticky inflation, and geopolitical chaos, protection and income outperform pie-in-the-sky narratives.

The Case Against Value: Why Growth Still Has Its Fans

Let’s be fair: there’s a reason growth dominated for so long. European tech and healthcare names—think ASML, Novo Nordisk, LVMH—are global champions. If AI, software, and medtech keep exploding, growth could surprise everyone (again). The iShares MSCI Europe Growth UCITS ETF (IEGR) has delivered a whopping 60% return since 2020, doubling the value ETF’s pace over the same period.

And there’s the risk that value is a value trap. Not every cheap bank or energy stock is a hidden gem—some are cheap for a reason. Aging demographics, regulation, and ESG pressures could choke returns. If US tech roars back in 2026, European growth might ride the coattails, especially as the Eurozone economy recovers.

If you want to outperform, you can’t just buy the cheapest stocks—you need to avoid the duds hiding in the value basket.

This Is the Pivot: How Europeans Should Invest in 2026

Here’s the action step nobody will say out loud: ditch the 60/40 or global blend. Go overweight European value—at least 50% of your equity allocation. Use the iShares MSCI Europe Value Factor UCITS ETF for scale, and add select dividend aristocrats (like AXA, Sanofi, Allianz) for stability and yield. Keep a minority growth position—fine, but only in the highest-quality names.

Why? Because the eurozone is entering a golden window: falling rates, stabilising energy, and a global rotation out of overpriced growth. By end-2026, I’m calling it: value will trounce growth by at least 5% per year in EUR terms—and you’ll want to be on the right side of that trade.

Don’t wait for more “confirmation.” The growth vs value stocks Europe 2026 debate is already over for those who look at the numbers and the macro. Position yourself now—or get left behind, again.

Disclaimer: This article reflects the author's opinion and is for educational purposes only. It does not constitute financial advice. Always do your own research before making investment decisions.